Company news
DaShenLin Pharmaceutical Group Co., Ltd. news in 2025
DaShenLin Pharmaceutical Group Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
December 19, 2025
Announcement on Convening the Q3 2025 Performance Briefing
December 1, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
November 21, 2025
Announcement on Resolutions of the 28th Meeting of the 4th Board of Directors
October 29, 2025
Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Semi-annual Dividend Distribution for 2025
October 22, 2025
Announcement on the Interest Payment of Convertible Corporate Bonds in 2025
October 14, 2025
Announcement on Progress in Providing Guarantees for Subsidiaries
September 29, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 17, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 15, 2025
Announcement on the Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale and the Completion of the Shareholding Reduction Plan
September 10, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
August 28, 2025
Announcement on the 2025 Follow-up Rating Result of Convertible Corporate Bonds
June 27, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
June 25, 2025
Announcement on Pledge of Shares of Controlling Shareholders
June 24, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 11, 2025
Announcement on Appointment of Strategic Consultant and Related Party Transactions
June 9, 2025
Announcement on Plan of Shareholding Reduction by Shareholder with Over 5% Shares
June 4, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 28, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 20, 2025
Announcement on 2024 Annual Profit Distribution Plan
April 25, 2025